Table: Zeria Pharm -2022/23 parent results
May 11 (Reuters)-
Zeria Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 32.96 31.96
(+3.1 pct) (+1.2 pct)
Operating 1.79 782 mln
(+129.2 pct) (+100.6 pct)
Recurring 2.74 1.59
(+71.8 pct) (+46.4 pct)
Net 2.16 1.39
(+55.0 pct) (+9.3 pct)
EPS 48.85 yen 30.85 yen
Ann Div 40.00 yen 35.00 yen 44.00 yen
-Q2 Div 18.00 yen 17.00 yen 22.00 yen
-Q4 Div 22.00 yen 18.00 yen 22.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T